What is red light therapy and how does it work?
Red light therapy — also known as photobiomodulation (PBM) or low-level laser therapy (LLLT) when referring to laser devices — uses specific wavelengths of light to trigger biological responses in skin cells without producing heat or UV radiation. The mechanism: light photons at specific wavelengths are absorbed by chromophores in the mitochondria of skin cells. The primary chromophore for red and near-infrared light is cytochrome c oxidase, a protein in the mitochondrial electron transport chain. When cytochrome c oxidase absorbs photons at 630–850nm wavelength, it increases ATP (cellular energy) production, stimulates reactive oxygen species signalling pathways, and upregulates gene expression for collagen and growth factors. This cascade of effects is measurable in controlled studies, making red light therapy one of the better-evidenced non-invasive skin treatments.
Red light vs blue light vs near-infrared: different wavelengths, different targets
LED devices use different wavelengths for different targets. Red light 630–660nm: penetrates to the dermis (2–3mm depth). Stimulates fibroblast activity, collagen synthesis, and wound healing. Clinical applications: fine lines, skin texture, and post-treatment recovery. Near-infrared 810–850nm: penetrates deeper (3–5mm), reaching dermal fibroblasts and potentially subdermal tissue. Used for deeper collagen remodelling and inflammatory conditions. Blue light 415–430nm: stays in the epidermis (surface layer). Targets porphyrins produced by C. acnes bacteria — blue light oxidises these porphyrins, killing bacteria without antibiotics. Used for acne treatment. Yellow light 570–590nm: targets haemoglobin and melanin; used for redness reduction, rosacea, and hyperpigmentation. Consumer LED masks typically offer red (630–660nm) and blue (415–430nm) as the primary wavelengths, which covers the two most widely used clinical applications.
What the clinical evidence shows for consumer devices
The key challenge with consumer LED data is that most clinical research used medical-grade devices (Omnilux, Dermalux, LLLT lasers) at irradiance levels of 40–80 mW/cm². Consumer devices typically deliver 5–30 mW/cm². A 2014 meta-analysis in the Journal of Investigative Dermatology found photobiomodulation significantly improved skin rejuvenation outcomes, but noted dose-dependency — devices delivering lower energy doses produced proportionally smaller effects. For blue light acne treatment: a 2016 Cochrane-adjacent review found blue light therapy (medical grade) significantly more effective than vehicle-only control for mild-to-moderate acne. For anti-aging: a 2014 study using Omnilux device (near-infrared) showed 87% of participants experienced measurable improvements in skin texture and 82% in wrinkle depth after 9 sessions. Consumer devices producing similar effects are plausible but require more frequent use to compensate for lower irradiance.
How to use an LED face mask correctly
Session duration: typically 10–20 minutes per session. More is not better — photobiomodulation follows a biphasic dose-response curve, meaning excessive dosing (too much light time) reverses the beneficial effects and produces inhibitory responses. Frequency: 3–5 sessions per week for the first 4–8 weeks (treatment phase), then reducing to 1–2 sessions per week for maintenance. Apply to clean, product-free skin — serums and sunscreens can partially block photon penetration. After the session: apply a hyaluronic acid serum or moisturiser immediately, as photobiomodulation temporarily increases skin permeability and enhances product absorption for approximately 30 minutes post-treatment. Eye protection: always use the provided eye shields or protective goggles. Close your eyes under the device. Even non-UV LED light at close range and high intensity can cause retinal stress with prolonged exposure.
Realistic expectations and timeline
Red light therapy is not a fast-result treatment. The collagen synthesis it stimulates operates on dermal timelines. A realistic expectation timeline: Weeks 1–2: improved skin hydration and slightly more even skin tone (the vascular and melanin effects are faster than structural collagen changes). Weeks 4–6: visible improvement in skin texture and early reduction in fine line depth. Months 2–3: measurable improvement in skin firmness and collagen density if regular sessions have been maintained. For acne (blue light): 4–6 weeks of consistent use to see meaningful reduction in active breakouts. Blue light does not address comedones (blackheads/whiteheads) — it targets only inflammatory C. acnes bacteria. The most common reason LED devices fail to deliver results: inconsistent use. Three sessions then stopping will produce no measurable dermal collagen change. Device protocols require sustained use over months, not weeks.